← Leaderboards
Kevin A Reynolds
Virginia Commonwealth University
$10,412,938
Attributed
$11,379,353
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$11,379,353 · 9
By mechanism
R01$10,646,647 · 6
R56$421,403 · 1
R41$166,303 · 1
R03$145,000 · 1
Top collaborators
- Jane X Kelly3 shared
Others in their field
Top investigators on “Antibiotics”
- Laurence H Baker · University Of Michigan At Ann Arbor$52,071,546
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,812,829
- Taha E Taha · Johns Hopkins University$37,363,329
- Urs Ochsner · Crestone, Inc.$36,950,837
- Deborah T Hung · Massachusetts General Hospital$36,871,538
- Ryan Cirz · Revagenix, Inc.$35,410,554
Research focus
AntibioticsStructureBiological FactorsBacteriaFatty Acid BiosynthesisAnabolismEnzymesPathway InteractionsBiologicalBiochemicalMutantSeriesGeneticDrug Design /Synthesis /ProductionInterestComplexStreptomycesAcyl Carrier ProteinHybridsAntimalarialsEnzymatic BiochemistryAntifungal AgentsFascinateGenes
Grant awards (36)
Novel Multiple-Stage Active Antimalarials$620,053
R01 · FY2021 · AI · contact PI
Novel Multiple-Stage Active Antimalarials$637,460
R01 · FY2020 · AI · contact PI
Novel Multiple-Stage Active Antimalarials$675,318
R01 · FY2019 · AI · contact PI
Phoslactomycins: Biosynthesis & Activity$354,288
R01 · FY2014 · AI · contact PI
Hygromycin A: Activity, Biosynthesis, Export, Resistance and Regulation$293,387
R01 · FY2014 · GM · contact PI
Phoslactomycins: Biosynthesis & Activity$333,079
R01 · FY2013 · AI · contact PI
Hygromycin A: Activity, Biosynthesis, Export, Resistance and Regulation$283,063
R01 · FY2013 · GM · contact PI
Phoslactomycins: Biosynthesis & Activity$354,415
R01 · FY2012 · AI · contact PI
Hygromycin A: Activity, Biosynthesis, Export, Resistance and Regulation$293,294
R01 · FY2012 · GM · contact PI
Hygromycin A: Activity, Biosynthesis, Export, Resistance and Regulation$304,592
R01 · FY2011 · GM · contact PI
Phoslactomycins: Biosynthesis & Activity$296,936
R01 · FY2011 · AI · contact PI
Deciphering the steps of prodiginine biosynthesis$584,988
R01 · FY2010 · GM · contact PI
Phoslactomycins: Biosynthesis & Activity$421,403
R56 · FY2010 · AI · contact PI
Deciphering the steps of prodiginine biosynthesis$383,101
R01 · FY2009 · GM · contact PI
Deciphering the steps of prodiginine biosynthesis$208,029
R01 · FY2009 · GM · contact PI
Deciphering the steps of prodiginine biosynthesis$371,274
R01 · FY2008 · GM · contact PI
Deciphering the steps of prodiginine biosynthesis$383,333
R01 · FY2007 · GM · contact PI
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target$274,061
R01 · FY2007 · AI · contact PI
CYCLOHEXANECARBOXYLIC ACID AND POLYKETIDE BIOSYNTHESIS$315,898
R01 · FY2006 · AI · contact PI
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target$282,246
R01 · FY2006 · AI · contact PI
CYCLOHEXANECARBOXYLIC ACID AND POLYKETIDE BIOSYNTHESIS$241,455
R01 · FY2005 · AI
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target$207,110
R01 · FY2005 · AI
CYCLOHEXANECARBOXYLIC ACID AND POLYKETIDE BIOSYNTHESIS$96,045
R01 · FY2005 · AI
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target$92,890
R01 · FY2005 · AI
CYCLOHEXANECARBOXYLIC ACID AND POLYKETIDE BIOSYNTHESIS$337,500
R01 · FY2004 · AI
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target$300,000
R01 · FY2004 · AI
CYCLOHEXANECARBOXYLIC ACID AND POLYKETIDE BIOSYNTHESIS$337,500
R01 · FY2003 · AI
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target$300,000
R01 · FY2003 · AI
ENGINEERING PRECURSOR SUPPLY FOR POLYKETIDE BIOSYNTHESIS$287,100
R01 · FY2003 · GM
CYCLOHEXANECARBOXYLIC ACID AND POLYKETIDE BIOSYNTHESIS$350,000
R01 · FY2002 · AI
ENGINEERING PRECURSOR SUPPLY FOR POLYKETIDE BIOSYNTHESIS$287,100
R01 · FY2002 · GM
ENGINEERING PRECURSOR SUPPLY FOR POLYKETIDE BIOSYNTHESIS$287,100
R01 · FY2001 · GM
KASIII-A TARGET FOR NOVEL ANTIBIOTICS$72,500
R03 · FY2001 · AI
ENGINEERING PRECURSOR SUPPLY FOR POLYKETIDE BIOSYNTHESIS$274,032
R01 · FY2000 · GM
ENGINEERED BIOSYNTHESIS OF NOVEL KETOLIDE ANTIBIOTICS$166,303
R41 · FY2000 · GM
KASIII-A TARGET FOR NOVEL ANTIBIOTICS$72,500
R03 · FY2000 · AI